Mitotane Market

Mitotane, sold under the brand name Lysodren, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and Cushing's syndrome. It is a derivative of the early insecticide DDT and an isomer of p,p'-DDD (4,4'-dichlorodiphenyldichloroethane) and is also known as 2,4'-(dichlorodiphenyl)-2,2-dichloroethane (o,p'-DDD).
Mitotane Market contains market size and forecasts of Mitotane in global, including the following market information:
Global Mitotane Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mitotane Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Mitotane companies in 2021 (%)
The global Mitotane market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mitotane include Bristol Meyers Squibb and HRA Pharma etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mitotane manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mitotane Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mitotane Market Segment Percentages, by Type, 2021 (%)
Tablet
Capsule
Global Mitotane Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mitotane Market Segment Percentages, by Application, 2021 (%)
Adrenal Cortical Carcinoma
Cushing's Syndrome
Global Mitotane Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mitotane Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mitotane revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mitotane revenues share in global market, 2021 (%)
Key companies Mitotane sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Mitotane sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Meyers Squibb
HRA Pharma